TY - JOUR
AU - Shilpa Rajagopal
AU - Jordan Westra
AU - Mukaila A. Raji
AU - Denise Wilkes
AU - Yong-Fang Kuo
A1 - 
AD - John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, US ; Department of Biostatistics & Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX, US yokuo@utmb.edu; Division of Geriatrics & Palliative Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, US ; Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, US ; Kuo, Yong-Fang,301 University Boulevard,Galveston,US,77555,University of Texas Medical Branch,yokuo@utmb.edu
BT - American Journal of Preventive Medicine
C5 - Opioids & Substance Use ; Healthcare Disparities; HIT & Telehealth
CP - 4
DB - APA PsycInfo®
DO - 10.1016/j.amepre.2023.11.011
IS - 4
JF - American Journal of Preventive Medicine
LA - English
PY - 2024
SN - 0749-3797, 0749-3797
SP - 635
EP - 644+
ST - Access to medications for opioid use disorder during COVID-19: Retrospective study of commercially insured patients from 2019–2022
T1 - Access to medications for opioid use disorder during COVID-19: Retrospective study of commercially insured patients from 2019–2022
T2 - American Journal of Preventive Medicine
TI - Access to medications for opioid use disorder during COVID-19: Retrospective study of commercially insured patients from 2019–2022
U1 - Opioids & Substance Use ; Healthcare Disparities; HIT & Telehealth
U3 - 10.1016/j.amepre.2023.11.011
VL - 66
VO - 0749-3797, 0749-3797
Y1 - 2024
ER -